Richard E. Chaisson - Publications

Body mass index and the risk of TB.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: July 03, 2026

Guiding principles for pragmatic randomised trials of tuberculosis treatments.

Journal: The Lancet. Infectious diseases

Published: March 30, 2026

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020.

Journal: Emerging infectious diseases

Published: January 06, 2026

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

Journal: The Lancet. Infectious diseases

Published: November 11, 2025

Stakeholder engagement to identify barriers to implementation and inform the development of point-of-care diagnostics for TB.

Journal: IJTLD open

Published: October 16, 2025

Safety of short-course weekly rifapentine and isoniazid (3HP) for TB preventive treatment at conception and during first trimester in women living with HIV: a secondary analysis of WHIP3TB trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 11, 2025

Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.

Journal: PLoS medicine

Published: September 01, 2025

Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective study.

Journal: The Lancet regional health. Southeast Asia

Published: August 24, 2025

Dynamics of Quantiferon-Gold Plus results in a large TB preventive treatment trial across three high-burden HIV/TB countries.

Journal: The Journal of infectious diseases

Published: August 04, 2025

Optimising child-friendly TB preventive treatment regimens.

Journal: IJTLD open

Published: June 06, 2025

Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB Trial.

Journal: Open forum infectious diseases

Published: June 03, 2025

Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis.

Journal: Nature communications

Published: May 13, 2025